OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PCHM55

Punjab Chemicals and Crop Protection Ltd

Diversified ChemicalsVerified

Punjab Chemicals and Crop Protection Ltd has a revenue of $2.42 billion and a gross profit of $940.9 million, indicating a gross margin of 38.8%. The company's operating income is $221.3 million, translating to an operating margin of 9.1%, and a net income of $134.4 million, or a net margin of 5.5%. These metrics suggest a relatively stable but not highly profitable business model compared to the industry median for Diversified Chemicals, which typically sees higher operating margins in the 12-15% range. The company's capital structure is not fully disclosed, but the absence of detailed balance sheet data and the lack of going-concern language in source documents suggest that liquidity risk could not be assessed. This lack of transparency may limit the ability to evaluate the company's short-term financial health and its capacity to meet obligations. Geographically and segment-wise, the company's exposure is not explicitly detailed in the available data. However, as a diversified chemicals firm, it likely operates across multiple product lines and geographic regions. The absence of segment-specific revenue breakdowns limits the ability to assess concentration risk or growth drivers within specific business units. The company's growth trajectory is not clearly defined in the available data. There are no specific numeric deltas or forward-looking guidance provided for the current or next fiscal year. The lack of detailed revenue history and forward-looking statements makes it difficult to assess the company's growth potential or strategic direction. Risk factors include the inability to assess liquidity risk due to missing balance sheet data and the absence of going-concern language in source documents. Additionally, the company's dilution potential is currently low, but the lack of detailed capital structure data means that the risk of future dilution cannot be fully evaluated. No adjustments have been applied to the valuation metrics due to the limited data availability. Recent events and filings do not provide specific details on the company's operations or strategic initiatives. The absence of recent transcripts or filings limits the ability to assess management's outlook or any material developments that may impact the company's performance.

30-day price · PCHM+97.20 (+9.5%)
Low$876.60High$1192.75Close$1115.90As of12 May, 00:00 UTC
Profile
CompanyPunjab Chemicals and Crop Protection Ltd
TickerPCHM.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Punjab Chemicals and Crop Protection Ltd is a diversified chemicals company engaged in the production and sale of agrochemicals, industrial chemicals, and allied products.

Classification. The company is classified under the Basic Materials economic sector, within the Chemicals business sector and Diversified Chemicals industry, with a classification confidence of 0.92.

Punjab Chemicals and Crop Protection Ltd has a revenue of $2.42 billion and a gross profit of $940.9 million, indicating a gross margin of 38.8%. The company's operating income is $221.3 million, translating to an operating margin of 9.1%, and a net income of $134.4 million, or a net margin of 5.5%. These metrics suggest a relatively stable but not highly profitable business model compared to the industry median for Diversified Chemicals, which typically sees higher operating margins in the 12-15% range. The company's capital structure is not fully disclosed, but the absence of detailed balance sheet data and the lack of going-concern language in source documents suggest that liquidity risk could not be assessed. This lack of transparency may limit the ability to evaluate the company's short-term financial health and its capacity to meet obligations. Geographically and segment-wise, the company's exposure is not explicitly detailed in the available data. However, as a diversified chemicals firm, it likely operates across multiple product lines and geographic regions. The absence of segment-specific revenue breakdowns limits the ability to assess concentration risk or growth drivers within specific business units. The company's growth trajectory is not clearly defined in the available data. There are no specific numeric deltas or forward-looking guidance provided for the current or next fiscal year. The lack of detailed revenue history and forward-looking statements makes it difficult to assess the company's growth potential or strategic direction. Risk factors include the inability to assess liquidity risk due to missing balance sheet data and the absence of going-concern language in source documents. Additionally, the company's dilution potential is currently low, but the lack of detailed capital structure data means that the risk of future dilution cannot be fully evaluated. No adjustments have been applied to the valuation metrics due to the limited data availability. Recent events and filings do not provide specific details on the company's operations or strategic initiatives. The absence of recent transcripts or filings limits the ability to assess management's outlook or any material developments that may impact the company's performance.
Key takeaways
  • Punjab Chemicals and Crop Protection Ltd operates in the Diversified Chemicals industry with a revenue of $2.42 billion and a net margin of 5.5%.
  • The company's liquidity risk could not be assessed due to missing balance sheet data and lack of going-concern language in source documents.
  • The company's growth trajectory and segment-specific performance are not clearly defined in the available data.
  • The company's dilution potential is currently low, but the lack of detailed capital structure data limits the ability to evaluate future dilution risk.
  • Recent events and filings do not provide specific details on the company's operations or strategic initiatives.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$2.42B
Gross profit$940.9M
Operating income$221.3M
Net income$134.4M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$9.33B$1.24B$834.6M$650.8M
FY-3$10.06B$1.04B$611.0M$391.1M
FY-2$9.34B$919.4M$535.8M$388.4M
FY-1$9.01B$710.4M$389.3M$267.2M
FY0$10.30B$874.1M$639.6M$432.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$5.57B$2.26B$0.00
FY-3$6.16B$2.81B$1.7M
FY-2$6.40B$3.30B
FY-1$8.01B$3.65B
FY0$8.23B$4.23B$150.2M
PeriodOCFCapExFCFSBC
FY-4$343.1M-$326.2M$650.8M
FY-3$582.1M-$373.5M$391.1M
FY-2$298.9M-$332.4M$388.4M
FY-1$252.2M-$336.1M$267.2M
FY0$855.4M-$457.4M$432.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$2.42B$221.3M$134.4M
FQ-6$2.42B$194.6M$123.7M
FQ-5$2.14B$127.5M$60.7M
FQ-4$2.02B$148.2M$70.5M
FQ-3$3.20B$278.6M$206.3M
FQ-2$2.55B$195.9M$185.4M
FQ-1$2.47B$206.9M$138.1M
FQ0$2.09B$188.2M$109.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6$6.95B$3.52B$154.0M
FQ-5
FQ-4$8.01B$3.65B
FQ-3
FQ-2$6.93B$4.00B$266.4M
FQ-1
FQ0$8.23B$4.23B$150.2M
PeriodOCFCapExFCFSBC
FQ-7
FQ-6$345.3M-$182.8M
FQ-5
FQ-4$252.2M-$336.1M
FQ-3
FQ-2$829.6M-$190.7M
FQ-1
FQ0$855.4M-$457.4M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Diversified Chemicals · cohort 83 companies
MetricPCHMActivity
Op margin9.1%6.3% medp25 2.1% · p75 9.6%above median
Net margin5.5%3.3% medp25 0.2% · p75 6.4%above median
Gross margin38.8%23.5% medp25 13.2% · p75 31.9%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-5.5% medp25 -11.2% · p75 -3.8%
Debt / equity42.1% medp25 16.7% · p75 82.4%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 01:40 UTC#efd09335
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 22:37 UTCJob: 46c1165d